glp 1 inhibitors GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes What is GLP-1 and Its

Led by Dr

Explore a thorough comparison of Semaglutide and other GLP-1 receptor agonists

There was an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, nephrolithiasis, interstitial nephritis and drug-induced pancreatitis.

But despite widespread use of these drugs by perimenopausal women, research has largely ignored the unique risks and potential opportunities for optimizing health that GLP-1s may pose for this population.

Obesity is a chronic disease associated with increased risk of obesity-related complications and mortality

Rare disorders and disease progression were not examined